Bianucci to sell Biofield's breast test in Italy:
This article was originally published in Clinica
Executive Summary
Atlanta, Georgia-based Biofield has appointed Bianucci di Bianucci as exclusive distributor of its Biofield diagnostic system (BDS) for the detection of breast cancer. The deal with the Lucca, Italy-based company is for three years. The product is used for a 15-minute noninvasive, office-based test, which helps to characterise the severity of a breast lesion and gives an immediate result. Bianucci says that Italy has one of highest rates of breast cancer in Europe.